Related Experiment Video
Updated: Nov 6, 2025
Author Spotlight: Advancing Therapeutic Strategies for Improving Pregnancy Rates by Analyzing Embryo-Endometrium Interactions
Published on: June 21, 2024
Correction to: Dehydroepiandrosterone sulphate (DHEAS) concentrations stringently regulate fertilization, embryo
Bindu N Chimote1, Natachandra M Chimote2
1IVF Embryology Laboratory, Vaunshdhara Fertility Centre, 9, Dr. Munje Marg, Congress Nagar, Nagpur, Maharashtra, India. bindunm10@yahoo.com.
Purpose:
Erratic oocyte-activation affects fertilization and embryo development. Dehydro-epiandrosterone sulphate (DHEAS) is present in theca/cumulus-granulosa cells, regulates the same calcium-pumps that cause calcium-oscillations in mice and its levels are altered in women with no or low fertilization rates. Yet no study has explored correlation of DHEAS with oocyte-activation. We proposed to implicate DHEAS as an oocyte-related factor in oocyte-activation by demonstrating that rectification of deviated (both lower/and higher than normal) DHEAS concentrations to normal post-treatment improves fertilization, embryo development rates.
Method:
Prospective Closed-Cohort. Recruited n = 750 (150 women/subgroup) in previously classified Low(A), Average/Control(B), High(C) D3-serum DHEAS groups. 50% women in both A and C groups received 3-months exposure to oral DHEAS and Metformin respectively. Also measured Follicular-fluid DHEAS levels. Compared embryologic, clinical outcomes: DHEAS untreated (A1) vs. treated (A2); metformin untreated (C1) vs. treated (C2) and A1/A2/C1/C2 against normal-control-B group. Also compared serum vs. FF-group results.
Results:
Significantly improved embryologic, clinical parameters in treated A2/C2 compared to untreated A1/C1 subgroups respectively. Post-treated improved parameters in A2/C2 were comparable with, whereas untreated A1/C1 sub-groups had significantly lower values than, normal-control B-group. Parameters differed significantly between Low, Medium, High FF-DHEAS groups. Results in serum vs. FF: A1 vs. LowFF, C1 vs. HighFF and A2/C2/B vs. MediumFF were comparable. Odds of fertilization, live-births increased in post-treatment A2/C2 subgroups. Fertilization rates strongly correlated with FF-DHEAS.
Conclusion:
Rectification of deviated DHEAS levels post-treatment significantly improves outcomes, comparable with those exhibited by normal-control DHEAS thresholds. DHEAS is the most promising endogenous oocyte-related factor influencing embryologic, clinical IVF outcomes possibly by affecting oocyte-activation.
Related Concept Videos
02:07Oogenesis
01:22Oogenesis
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
01:27Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:24In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...